PRICES OF BIOSIMILARS IN THE US

被引：0
|
作者：
Gannu, L. [1 ]
Daniels, K. [2 ]
Seoane-Vazquez, E. [1 ]
Szeinbach, S. L. [3 ]
机构：
[1] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
[2] MCPHS Univ, Boston, MA USA
[3] Ohio State Univ, Columbus, OH 43210 USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP108
引用
收藏
页码：A33 / A33
页数：1
相关论文
共 50 条
  • [1] Comparison of Uptake and Prices of Biosimilars in the US, Germany, and Switzerland
    Carl, David L.
    Laube, Yannic
    Serra-Burriel, Miquel
    Naci, Huseyin
    Ludwig, Wolf-Dieter
    Vokinger, Kerstin N.
    [J]. JAMA NETWORK OPEN, 2022, 5 (12) : E2244670
  • [2] US to accept biosimilars?
    Houlton, Sarah
    [J]. CHEMISTRY & INDUSTRY, 2007, (13) : 6 - 6
  • [3] US debut for biosimilars
    Houlton, Sarah
    [J]. CHEMISTRY & INDUSTRY, 2015, 79 (04) : 25 - 25
  • [4] Challenges with the Introduction of Biosimilars in the US
    Stevenson, James G.
    [J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (03) : 93 - 96
  • [5] Biosimilars: The US Regulatory Framework
    Christl, Leah A.
    Woodcock, Janet
    Kozlowski, Steven
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 68, 2017, 68 : 243 - 254
  • [6] BIOSIMILARS Two biosimilars get US panel's nod
    Mccoy, Michael
    [J]. CHEMICAL & ENGINEERING NEWS, 2016, 94 (29) : 15 - 15
  • [7] WILL US PAYERS CHAMPION BIOSIMILARS?
    Malik, A. N.
    Cox, J.
    Keeping, K.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A265 - A265
  • [8] Biosimilars Regulation in the US: The Challenges
    Ridley-Smith, Philip
    [J]. BIOPHARM INTERNATIONAL, 2010, 23 (11) : 58 - 58
  • [9] US state legislation on biosimilars substitution
    Derbyshire, Michelle
    [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2013, 2 (03): : 155 - 156
  • [10] First biosimilars trickle into US pathway
    [J]. Nature Biotechnology, 2014, 32 : 855 - 855
12345